Market Cap: $1.47B
AI
AnaptysBio, Inc.
ANAB
NASDAQUSD
Market Cap: $1.47B
AnaptysBio (Ticker: ANAB) announces a strategic pivot towards a royalty-focused business model following the spin-off of First Tracks Biotherapeutics, aiming to enhance its financial stability and sha…
AnaptysBio (ANAB) has recently announced the successful completion of its spin-off of First Tracks Biotherapeutics, marking a significant strategic shift in its operational focus. AnaptysBio's Strateg…
Vanda Pharmaceuticals Advances Rare Disease Treatment with BLA Submission for Imsidolimab Vanda Pharmaceuticals Inc. takes a significant step in the treatment of rare inflammatory skin conditions by s…
Vanda Pharmaceuticals Advances Rare Disease Treatment with BLA Submission for Imsidolimab Vanda Pharmaceuticals Inc. makes a significant move in the biopharmaceutical landscape with the submission of…
Vanda Pharmaceuticals Advances Rare Disease Treatment with BLA Submission Vanda Pharmaceuticals Inc. moves forward in the fight against generalized pustular psoriasis (GPP) with the recent submission…
AnaptysBio Faces Legal Challenge in Patent Dispute With GSK's Tesaro Inc. AnaptysBio, Inc., a prominent player in the biotechnology sector, finds itself embroiled in a legal battle as GSK plc's subsid…
Legal Turbulence in Biotechnology: AnaptysBio Faces Lawsuit from GSK's Tesaro In a notable development within the biotechnology sector, AnaptysBio, Inc. finds itself embroiled in a lawsuit filed by Te…
AnaptysBio Faces Legal Challenge in Patent Dispute with GSK Subsidiary AnaptysBio, Inc. finds itself embroiled in a significant legal battle as GSK plc's subsidiary, Tesaro Inc., files a lawsuit again…
AnaptysBio Explores Strategic Separation to Enhance Focus and Growth AnaptysBio, Inc. announces its plans to explore a strategic separation of its operations into two independent, publicly traded comp…
ANAB Launches Digital Technology Initiative to Revolutionize Accreditation Processes The American National Standards Institute (ANAB) announces the launch of its Digital Technology Initiative (DTI), a…
Advancing Digital Transformation: ANAB Launches Digital Technology Initiative On September 4, 2025, the American National Standards Institute (ANAB) unveils its ambitious Digital Technology Initiative…
AnaptysBio Faces Mixed Analyst Ratings Amid Biopharmaceutical Challenges AnaptysBio, a prominent player in the biopharmaceutical industry, stands at a crossroads as it navigates a competitive landscap…
AnaptysBio Faces Divergent Analyst Opinions Amidst Market Uncertainty In recent months, AnaptysBio (ANAB) has garnered attention from analysts offering a wide spectrum of opinions regarding the biotec…
AnaptysBio: Navigating the Complex Landscape of Biotech Analysis In the competitive biotechnology sector, AnaptysBio is at a critical juncture marked by diverse analyst opinions regarding its market p…
AnaptysBio Advances in Therapeutic Development Amid Evolving Market Conditions AnaptysBio, a clinical-stage biotechnology company, continues to make strides in the development of its innovative therap…
New Global Standards Support Safety in Aerospace Sector AnaptysBio, a company rooted in the biotechnology sector, is poised to benefit from the recent expansion of the ANSI National Accreditation Boar…
Strengthening Workplace Safety Initiatives: SGS Achieves ISO 45001 Accreditation SGS, a global leader in testing, inspection, and certification, has recently secured accreditation from the ANSI Nation…
Navigating Cyber Workforce Accreditation: ANAB's Upcoming Webinar The ANSI National Accreditation Board (ANAB) announces a significant webinar focused on the U.S. Department of Defense (DoD) Cyber Wor…